Pilapil, Preciouse Al B.
HRN: 17-91-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/24/2024
11/30/2024
IVT
750mg
Q8
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes